Genomics England partners with the NHS to provide whole genome sequencing diagnostics. It also provides a secure Research Environment and advanced technology that enable researchers to discover new medical insights and develop treatments.
Ionis is unlocking the rapidly expanding potential of RNA- and DNA-targeted medicines to enable better futures for people living with serious diseases.